haloperidol and 3-hydroxymethyl-2,2,5,5-tetramethylpyrroline-n-oxyl

haloperidol has been researched along with 3-hydroxymethyl-2,2,5,5-tetramethylpyrroline-n-oxyl in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishida, S; Ogata, T; Yokoyama, H	1

Other Studies

1 other study(ies) available for haloperidol and 3-hydroxymethyl-2,2,5,5-tetramethylpyrroline-n-oxyl

Article	Year
In vivo temporal EPR study using a region-selected intensity determination method to estimate cerebral reducing ability in rats treated with olanzapine. Magnetic resonance imaging, 2010, Volume: 28, Issue:6 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Blood-Brain Barrier; Cerebral Cortex; Corpus Striatum; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Half-Life; Haloperidol; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Male; Models, Animal; Olanzapine; Oxidation-Reduction; Prefrontal Cortex; Pyrrolidines; Rats; Rats, Wistar	2010

Article

Year

In vivo temporal EPR study using a region-selected intensity determination method to estimate cerebral reducing ability in rats treated with olanzapine.

Magnetic resonance imaging, 2010, Volume: 28, Issue:6

Topics: Animals; Antipsychotic Agents; Benzodiazepines; Blood-Brain Barrier; Cerebral Cortex; Corpus Striatum; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Half-Life; Haloperidol; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Male; Models, Animal; Olanzapine; Oxidation-Reduction; Prefrontal Cortex; Pyrrolidines; Rats; Rats, Wistar

2010